Glaxo (GSK) Rejects Unilever’s $68B Bid for Consumer Business

Glaxo (GSK) rejects an offer from Unilever to acquire its consumer business worth 50 billion pounds ($68 billion). However, Unilever is likely to pursue the acquisition of the business.

Leave a comment

Your email address will not be published. Required fields are marked *